New marine‑derived compounds trigger death of aggressive breast cancer cells in laboratory tests

Why it matters

Breast cancer, especially the triple‑negative form that lacks common hormone targets, remains a leading cause of illness worldwide. Because treatment options are limited, scientists are searching for new drugs in unconventional places, such as marine organisms. Marine sponges and the microbes that live inside them have long been known to produce chemicals that can affect human cells, offering a promising source of future medicines.

“Researchers isolated two previously unknown chemicals, named Unguisol A and Unguisol B, from the fungus Aspergillus unguis that lives inside the marine sponge Aaptos suberitoides.”What the study found

What the study found

Researchers isolated two previously unknown chemicals, named Unguisol A and Unguisol B, from the fungus Aspergillus unguis that lives inside the marine sponge Aaptos suberitoides. In cell‑culture experiments, both compounds caused early apoptosis (programmed cell death, p < 0.01) and halted the cell‑division cycle at the DNA‑copying stage (S phase, p < 0.05) in MDA‑MB‑231 breast cancer cells, while sparing normal HaCat skin cells. The compounds also lowered the messenger‑RNA (mRNA) levels of the survival genes BCL2L1 and AKT1 (p < 0.01), suggesting a molecular route for their anti‑cancer effect.

What it means for people

These findings provide a proof‑of‑concept that chemicals from marine fungal symbionts can selectively kill aggressive breast cancer cells. The work gives cancer researchers new molecular leads to explore for drug development, potentially expanding future treatment options for patients with hard‑to‑treat breast tumors.